Phase 2 Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been newly diagnosed with breast cancer that is both ER-negative and HER2-negative (a subtype sometimes called "triple-negative" or similar), confirmed through a tissue or cell sample test
• People with stage II or III breast cancer that doctors have assessed as suitable for chemotherapy given before surgery, with the goal of surgically removing the cancer afterward
• People whose tumor measures at least 2 cm in size based on a physical examination or imaging scan, or people with cancer that has spread to nearby lymph nodes regardless of tumor size
• People who have not yet received any treatment for this cancer
• People aged 18 years or older; both males and females are eligible
• People who are in good to fully active general health, as measured by a standard medical scoring scale (ECOG score of 0 or 1) (confirm with trial site)
• People whose blood counts, heart function, and organ function meet the required health thresholds (confirm with trial site for specific values)
• Women who could become pregnant must have a negative pregnancy test within 30 days before joining and must use effective contraception throughout the study
• People who are able to understand the study information and sign a written consent form

Who may not be able to join:

• People who have had another invasive cancer within the past 5 years, with the exception of certain treated skin cancers or a specific non-invasive cervical condition
• People who have received chemotherapy, immunotherapy, targeted therapy, or radiation treatment within the past 12 months
• People whose breast cancer has spread to other parts of the body (stage IV/metastatic)
• People who have received any vaccine within 30 days before the first study treatment
• People with serious ongoing medical conditions affecting the whole body
• People with active infections, including but not limited to HIV, hepatitis B, hepatitis C, or tuberculosis
• People with serious heart conditions, such as a heart attack, acute coronary event, or certain heart procedures within the past 6 months, or moderate-to-severe heart failure
• Women who are currently breastfeeding (breastfeeding would need to be stopped during the study)
• People with a known allergy to the study drug or any of its ingredients
• People whom the trial investigators consider unsuitable for any other medical reason

Important: Always verify eligibility with the trial site directly before applying.